Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species.

Yukawa-Muto Y, Kamiya T, Fujii H, Mori H, Toyoda A, Sato I, Konishi Y, Hirayama A, Hara E, Fukuda S, Kawada N, Ohtani N

DOI: 10.1002/hep4.1954
Published: 2022 Aug
Container: Hepatology communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/hep4.1954,
  title = {Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species.},
  author = {Yukawa-Muto Y and Kamiya T and Fujii H and Mori H and Toyoda A and Sato I and Konishi Y and Hirayama A and Hara E and Fukuda S and Kawada N and Ohtani N},
  year = {2022},
  journal = {Hepatology communications},
  doi = {10.1002/hep4.1954},
  url = {https://doi.org/10.1002/hep4.1954}
}

RIS

TY  - JOUR
TI  - Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species.
AU  - Yukawa-Muto Y
AU  - Kamiya T
AU  - Fujii H
AU  - Mori H
AU  - Toyoda A
AU  - Sato I
AU  - Konishi Y
AU  - Hirayama A
AU  - Hara E
AU  - Fukuda S
AU  - Kawada N
AU  - Ohtani N
PY  - 2022
JO  - Hepatology communications
DO  - 10.1002/hep4.1954
UR  - https://doi.org/10.1002/hep4.1954
ER  -

APA

Y, Y., T, K., H, F., H, M., A, T., I, S., Y, K., A, H., E, H., S, F., N, K., & N, O. (2022). Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species.. Hepatology communications. https://doi.org/10.1002/hep4.1954

Source records

pubmed · retrieved 2026-09-26T20:16:02.282Z